A5037858718- Telemedicine and Telehealth Implementation
- Effects of Vibration on Health
- Mobile Health and mHealth Applications
- Healthcare Systems and Technology
- Circadian rhythm and melatonin
- Primary Care and Health Outcomes
- Patient Satisfaction in Healthcare
- Multiple Sclerosis Research Studies
- COVID-19 and healthcare impacts
- Amyotrophic Lateral Sclerosis Research
Johannes Kepler University of Linz
2023-2025
Medical University of Vienna
2022-2024
ABSTRACT Introduction This study investigates the differences in patient care across various organisational forms of general practitioners (GPs) Upper Austria. Methods Data was collected from GPs Austria, examining demographics, prescription patterns, staff employment, services offered and proximity practices to hospitals. The variability recording visit reasons also analysed. Results Of 30 participating (Response Rate 5.1%), 17 worked single practices, 7 group 6 PHC units. In our sample,...
The SARS-CoV2 pandemic as well the implementation of public health measures to decrease spread virus re-sparked call for "virtual" or "distance" treatments. This paper aimed assess use video consultations, up-to-dateness practice websites, and views GPs on whether eHealth is a positive aspect future their practices in publicly -funded primary healthcare facilities Austria.The cross-sectional online questionnaire, part PRICOV-19 study, was conducted from December 2020 until July 2021. We...
Background Fatigue is a common symptom in people with multiple sclerosis (pwMS) that significantly impairs quality of life. Bright light therapy may be cheap treatment option little to no adverse events. Objectives To evaluate the effectiveness bright as for MS-related fatigue. Methods This was randomized sham-controlled trial including 26 pwMS Severity Scale (FSS) Score ≥36. Participants were assigned receive either white ( n = 13) or dim red (sham-intervention; 13). used respective...
To translate, culturally adapt, and validate the Neurological Sleep Index-Multiple Sclerosis (NSI-MS) for use in Austrian German-speaking populations with multiple sclerosis.